Stammdaten
Unternehmen
| Name | BioAge Labs, Inc. |
|---|---|
| Ticker | BIOA |
| CIK | 0001709941 |
Branche
| SIC-Code | 2834 |
|---|---|
| Beschreibung | Pharmaceutical Preparations |
Wertpapier
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Titel | BioAge Labs, Inc. |
Status
| Zuletzt geprüft | 2026-03-20 22:36:39.69562 |
|---|
Fondsaktivität (letzte 3 Quartale)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-02 | RUBIN PAUL D | Officer, Chief Medical Officer | Open Market Sale | -7,433 | 20.30 | -150,889.90 | -24,9% | |
| 2026-02-02 | RUBIN PAUL D | Officer, Chief Medical Officer | Open Market Sale | -7,433 | 18.75 | -139,368.75 | -23,0% | |
| 2026-01-13 | GOLDSTEIN DOV A MD | Officer, Chief Financial Officer | Open Market Sale | -8,974 | 18.43 | -165,371.08 | -27,3% | |
| 2026-01-13 | GOLDSTEIN DOV A MD | Officer, Chief Financial Officer | Open Market Sale | -4,440 | 19.45 | -86,369.54 | -14,3% | |
| 2026-01-13 | GOLDSTEIN DOV A MD | Officer, Chief Financial Officer | Open Market Sale | -11,663 | 20.54 | -239,548.69 | -39,5% | |
| 2026-01-13 | GOLDSTEIN DOV A MD | Officer, Chief Financial Officer | Open Market Sale | -1,923 | 21.08 | -40,538.38 | -6,7% | |
| 2026-01-13 | Fortney Kristen | Director, Officer, Chief Executive Officer | Open Market Sale | -233,107 | 18.12 | -4,223,036.34 | -697,0% | |
| 2026-01-02 | RUBIN PAUL D | Officer, Chief Medical Officer | Open Market Sale | -7,433 | 12.85 | -95,490.26 | -15,8% | |
| 2025-12-09 | RUBIN PAUL D | Officer, Chief Medical Officer | Open Market Sale | -18,000 | 12.00 | -216,000.00 | -35,7% | |
| 2025-12-04 | RUBIN PAUL D | Officer, Chief Medical Officer | Open Market Sale | -68,897 | 10.19 | -701,908.86 | -115,9% |
Top-Fondshalter (aktuelles Quartal)
Keine Fondsdaten für das aktuelle Quartal vorhanden.